Valuation Abbott Laboratories Wiener Boerse

Stocks

End-of-day quote Wiener Boerse 09/10/2026			5-day change	1st Jan Change
88.96 ^EUR	+2.28%		+3.39%	-16.04%

10-09	Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase	MT
10-07	Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	172,346	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-20.89%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	196,285	193,303	189,613
Change	-	-20.41%	0.28%	1.92%	9.66%	-11.69%	-1.52%	-1.91%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	29.2x	22.6x	19.8x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.6x	3.45x	3.27x
PEG	-	-36.9x	-2x	0x	-0.7x	-3.57x	0.8x	1.4x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.43x	3.16x	2.96x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	3.91x	3.54x	3.25x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	15.1x	13.4x	11.9x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	16.7x	14.8x	13.2x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	26x	21.7x	19.8x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.84%	4.62%	5.06%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.57	2.741	2.898
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.58%	2.75%	2.91%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.416	4.402	5.024
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	75.2%	62.3%	57.7%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,203	54,532	58,260
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,982	14,468	15,892
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,720	13,022	14,320
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,212	7,894	8,780
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	99.60	99.60	99.60
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,730,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	29.16x	3.91x	15.12x	2.58%	172B
MEDTRONIC PLC	18.92x	3.45x	12.33x	3.18%	113B
STRYKER CORPORATION	21.59x	4.24x	14.82x	1.3%	106B
ESSILORLUXOTTICA	25.92x	2.55x	10.24x	2.77%	75.31B
CENCORA, INC.	17.73x	0.21x	12.94x	0.73%	61.8B
HOYA CORPORATION	30.68x	7.58x	19.64x	1.3%	52.93B
BECTON, DICKINSON AND COMPANY	35.41x	3.42x	11.72x	2.14%	50.05B
IDEXX LABORATORIES, INC.	35.08x	8.72x	24.53x	-.--%	40.81B
DEXCOM, INC.	33.8x	5.92x	18.59x	-.--%	31.74B
Average	27.59x	4.44x	15.55x	1.56%	78.28B
Weighted average by Cap.	26.13x	4.03x	14.71x	1.95%